-
2021-05-27Butaprost is a selective prostaglandin E receptor (EP2) agonist. Butaprost can effectively mitigate kidney fibrogenesis in various fibrosis models. -
2019-04-11MK-0429, an orally active αvβ3 inhibitor, is a potential therapeutic agent for the prevention of kidney fibrosis, melanoma and osteoporosis.
Categories
Diseases
Targets
Archives
- May 2021 (1)
- April 2019 (1)
